Comparison of the Vaginal environment of Macaca mulatta and Macaca nemestrina Throughout the Menstrual Cycle

American Journal of Reproductive Immunology

Volumn 71, Issue 4, 2014, Pages 322-329

  Hadzic, Sarah V ^a   Wang, Xiaolei ^a   Dufour, Jason ^a   Doyle, Lara ^a   Marx, Preston A ^a   Lackner, Andrew A ^a   Paulsen, Daniel B ^b   Veazey, Ronald S ^a  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Epithelium; Estradiol; Macaca nemestrina; Menstrual cycle; Mucosa; Progesterone; rhesus macaque; SIV HIV transmission; Vagina

Indexed keywords

ESTRADIOL; PROGESTERONE;

ANATOMY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOPSY; COMPARATIVE STUDY; CONTROLLED STUDY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE GENITAL TRACT PARAMETERS; HORMONE DETERMINATION; KERATINIZATION; LUTEAL PHASE; MACACA NEMESTRINA; MENSTRUAL CYCLE; NONHUMAN; PRIORITY JOURNAL; PROGESTERONE BLOOD LEVEL; RHESUS MONKEY; VAGINA; VAGINA EPITHELIUM; VAGINA FLORA; VAGINA MUCOSA; VAGINAL BIOPSY; VAGINAL EPITHELIAL THICKNESS; VIRUS TRANSMISSION; ANATOMY AND HISTOLOGY; ANIMAL; BLOOD; DISEASE PREDISPOSITION; FOLLICULAR PHASE; MUCOSA; PATHOGENICITY; PHYSIOLOGY; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; TRANSMISSION;

ANIMALS; DISEASE SUSCEPTIBILITY; ESTRADIOL; FEMALE; FOLLICULAR PHASE; LUTEAL PHASE; MACACA MULATTA; MACACA NEMESTRINA; MUCOUS MEMBRANE; PROGESTERONE; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; SIMIAN IMMUNODEFICIENCY VIRUS; VAGINA;

EID: 84895822453     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/aji.12201     Document Type: Article

References (27)

1. Shattock RJ, Moore JP: Inhibiting sexual transmission of HIV-1 infection. Nat Rev Microbiol 2003; 1:25-34.
2. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de Bruyn G, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM: Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2012; 12:19-26.
3. Veazey RS, Shattock RJ, Klasse PJ, Moore JP. Animal models for microbicide studies. Curr HIV Res 2012; 10:79-87.
4. Walker ML, Gordon TP, Wilson ME: Menstrual cycle characteristics of seasonally breeding rhesus monkeys. Biol Reprod 1983; 29:841-848.
5. Patton DL, Sweeney YT, Agnew KJ, Balkus JE, Rabe LK, Hillier SL: Development of a nonhuman primate model for Trichomonas vaginalis infection. Sex Transm Dis 2006; 33:743-746.
6. Henning T, Fakile Y, Phillips C, Sweeney E, Mitchell J, Patton D, Sturdevant G, Caldwell HD, Secor WE, Papp J, Hendry RM, McNicholl J, Kersh E: Development of a pigtail macaque model of sexually transmitted infection/HIV coinfection using Chlamydia trachomatis, Trichomonas vaginalis, and SHIV(SF162P3). J Med Primatol 2011; 40:214-223.
7. Klatt NR, Canary LA, Vanderford TH, Vinton CL, Engram JC, Dunham RM, Cronise HE, Swerczek JM, Lafont BA, Picker LJ, Silvestri G, Brenchley JM: Dynamics of simian immunodeficiency virus SIVmac239 infection in pigtail macaques. J Virol 2012; 86:1203-1213.
8. Klatt NR, Harris LD, Vinton CL, Sung H, Briant JA, Tabb B, Morcock D, McGinty JW, Lifson JD, Lafont BA, Martin MA, Levine AD, Estes JD, Brenchley JM: Compromised gastrointestinal integrity in pigtail macaques is associated with increased microbial translocation, immune activation, and IL-17 production in the absence of SIV infection. Mucosal Immunol 2010; 3:387-398.
9. Otten RA, Adams DR, Kim CN, Jackson E, Pullium JK, Lee K, Grohskopf LA, Monsour M, Butera S, Folks TM: Multiple vaginal exposures to low doses of R5 simian-human immunodeficiency virus: strategy to study HIV preclinical interventions in nonhuman primates. J Infect Dis 2005; 191:164-173.
10. Vishwanathan SA, Guenthner PC, Lin CY, Dobard C, Sharma S, Adams DR, Otten RA, Heneine W, Hendry RM, McNicholl JM, Kersh EN: High susceptibility to repeated, low-dose, vaginal SHIV exposure late in the luteal phase of the menstrual cycle of pigtail macaques. J Acquir Immune Defic Syndr 2011; 57:261-264.
11. Marx PA, Spira AI, Gettie A, Dailey PJ, Veazey RS, Lackner AA, Mahoney CJ, Miller CJ, Claypool LE, Ho DD, Alexander NJ: Progesterone implants enhance SIV vaginal transmission and early virus load. Nat Med 1996; 2:1084-1089.
12. Kell PD, Barton SE, Edmonds DK, Boag FC: HIV infection in a patient with Meyer-Rokitansky-Kuster-Hauser syndrome. J R Soc Med 1992; 85:706-707.
13. Sodora DL, Gettie A, Miller CJ, Marx PA: Vaginal transmission of SIV: assessing infectivity and hormonal influences in macaques inoculated with cell-free and cell-associated viral stocks. AIDS Res Hum Retroviruses 1998; 14(Suppl 1):S119-S123.
14. Poonia B, Walter L, Dufour J, Harrison R, Marx PA, Veazey RS: Cyclic changes in the vaginal epithelium of normal rhesus macaques. J Endocrinol 2006; 190:829-835.
15. Mauck CK, Callahan MM, Baker J, Arbogast K, Veazey R, Stock R, Pan Z, Morrison CS, Chen-Mok M, Archer DF, Gabelnick HL: The effect of one injection of Depo-Provera on the human vaginal epithelium and cervical ectopy. Contraception 1999; 60:15-24.
16. Blakley GB, Beamer TW, Dukelow WR: Characteristics of the menstrual cycle in nonhuman primates. IV. Timed mating in Macaca nemestrina. Lab Anim 1981; 15:351-353.
17. Hendricks AG, Dukelow WR: Biology and management. In Nonhuman Primates in Biomedical Research. BT Bennett, CR Abee (eds). London, Academic Press, 1995, pp147-191.
18. Smith SM, Mefford M, Sodora D, Klase Z, Singh M, Alexander N, Hess D, Marx PA: Topical estrogen protects against SIV vaginal transmission without evidence of systemic effect. AIDS 2004; 18:1637-1643.
19. Panjari M, Davis SR: Vaginal DHEA to treat menopause related atrophy: a review of the evidence. Maturitas 2011; 70:22-25.
20. Heffron R, Donnell D, Rees H, Celum C, Mugo N, Were E, de BruynG, Nakku-Joloba E, Ngure K, Kiarie J, Coombs RW, Baeten JM. Use of hormonal contraceptives and risk of HIV-1 transmission: a prospective cohort study. Lancet Infect Dis 2011; 12:19-26.
21. Chateau D, Geiger JM, Samama B, Boehm N: Vaginal keratinization during the estrous cycle in rats: a model for evaluating retinoid activity. Skin Pharmacol 1996; 9:9-16.
22. Rehm S, Stanislaus DJ, Williams AM: Estrous cycle-dependent histology and review of sex steroid receptor expression in dog reproductive tissues and mammary gland and associated hormone levels. Birth Defects Res B Dev Reprod Toxicol 2007; 80:233-245.
23. Tripathi G: Antagonistic effects of estradiol dipropionate and progesterone on the histology of the vagina and uterus of the mouse. J Exp Zool 1984; 232:151-155.
24. Spear GT, Gilbert D, Sikaroodi M, Doyle L, Green L, Gillevet PM, Landay AL, Veazey RS: Identification of rhesus macaque genital microbiota by 16S pyrosequencing shows similarities to human bacterial vaginosis: implications for use as an animal model for HIV vaginal infection. AIDS Res Hum Retroviruses 2010; 26:193-200.
25. Mirmonsef P, Gilbert D, Veazey RS, Wang J, Kendrick SR, Spear GT. A comparison of lower genital tract glycogen and lactic acid levels in women and macaques: implications for HIV and SIV susceptibility. AIDS Res Hum Retroviruses 2011; 28:76-81.
26. Quinn TC, Overbaugh J: HIV/AIDS in women: an expanding epidemic. Science 2005; 308:1582-1583.
27. Baeten JM, Lavreys L, Overbaugh J: The influence of hormonal contraceptive use on HIV-1 transmission and disease progression. Clin Infect Dis 2007; 45:360-369.